Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV [electronic resource]
Producer: 20210318Description: 613-621 p. digitalISSN:- 1744-8379
- Adult
- Aged
- Double-Blind Method
- Female
- Follow-Up Studies
- Health Care Costs -- statistics & numerical data
- Hematopoietic Stem Cell Transplantation -- economics
- Herpes Zoster -- economics
- Herpes Zoster Vaccine -- administration & dosage
- Humans
- Immunocompromised Host
- Longitudinal Studies
- Male
- Middle Aged
- Neuralgia, Postherpetic -- economics
- Prospective Studies
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.